NHS England: Clinical commissioning policy statement for the treatment of drug-resistant TB

The National Health Service (NHS) in England released Clinical commissioning policy statement, and accompanying documents, for the treatment for defined patients with rifampicin-resistant TB, multidrug-resistant TB, pre-extensively drug-resistant TB and extensively drug-resistant TB including bedaquiline and delamanid (all ages).